Eckert & Ziegler Strahlen- Und Medizintechnik AG (ETR:EUZ) | Finanzwire

Basculer en Français

11114	Companies
244627	Keywords
172664	Articles
131840	Press releases

Headlines Articles Press releases Eckert & Ziegler Strahlen- Und Medizintechnik AG

Home
Companies
Eckert & Ziegler Strahlen- Und Medizintechnik AG

PRESS RELEASE

published on 03/21/2024 at 10:00, 2 years 6 months ago

Eckert & Ziegler Receives MDR Certification for Prostate Seeds, Paving the Way for Long-term Supply
Eckert & Ziegler BEBIG GmbH, a subsidiary of Eckert & Ziegler SE, obtains MDR certification for proprietary prostate seeds from DEKRA Certification B.V., ensuring patient safety and long-term supply within the EU

DEKRA Certification Eckert & Ziegler MDR Certification Prostate Seeds Brachytherapy
BRIEF

published on 03/19/2024 at 19:51, 2 years 6 months ago

Eckert & Ziegler Announces Dividend Cut to Fund Future Investments

Investment Eckert & Ziegler Financial Forecast Dividend Reduction Radiopharmaceuticals
PRESS RELEASE

published on 03/19/2024 at 19:46, 2 years 6 months ago

EQS-Adhoc: Eckert & Ziegler Reduces Dividend to Finance Future Investments. Earnings Growth Expected for 2024.
Eckert & Ziegler reduces dividend to fund future investments, aiming for earnings growth in 2024. Details on financial performance and strategic moves disclosed

Financial Performance Eckert & Ziegler Earnings Growth Dividend Reduction Strategic Investments
BRIEF

published on 03/19/2024 at 10:58, 2 years 6 months ago

Eckert & Ziegler Transitions to Societas Europaea

Corporate Governance Shareholder Rights Eckert & Ziegler SE Societas Europaea Legal Transition
PRESS RELEASE

published on 03/19/2024 at 10:53, 2 years 6 months ago

Eckert & Ziegler Completes Change of Legal Form to SE
Eckert & Ziegler completes change of legal form to SE, maintaining shareholder equity and operations. The company is a leading specialist in nuclear medicine and radiation therapy

Eckert & Ziegler Legal Form SE Nuclear Medicine Radiation Therapy
BRIEF

published on 02/28/2024 at 10:00, 2 years 7 months ago

Eckert & Ziegler Expands Ga-68 Activities in Japan in Collaboration with Novartis

Eckert & Ziegler Medical Imaging Diagnostic Gallium-68 Novartis Pharma KK
PRESS RELEASE

published on 02/28/2024 at 10:00, 2 years 7 months ago

Eckert & Ziegler Extends Ga-68 Activities in Japan
Eckert & Ziegler extends Ga-68 activities in Japan in alliance with Novartis Pharma K.K. Clinical trial with GalliaPharm generator for Ga-68. Collaboration to enhance cancer therapies and diagnostics in Japan

Eckert & Ziegler Clinical Trial Japan Ga-68 Radiopharmaceutical Industry
PRESS RELEASE

published on 01/31/2024 at 14:00, 2 years 8 months ago

Eckert & Ziegler to Supply Nucleus Radiopharma with Therapeutic Radioisotopes Ac-225 and Lu-177
Eckert & Ziegler to supply Nucleus Radiopharma with therapeutic radioisotopes Ac-225 and Lu-177 for cancer care, enabling advancement in radiotherapies and clinical development

Cancer Care Eckert & Ziegler Nucleus Radiopharma Therapeutic Radioisotopes Radiotherapies
PRESS RELEASE

published on 01/23/2024 at 08:00, 2 years 8 months ago

Eckert & Ziegler and Full-Life Technologies Sign Actinium-225 Supply Agreement for Next Generation Radiopharmaceuticals
Eckert & Ziegler (ISIN DE0005659700, SDAX) and Full-Life Technologies have signed an agreement for the supply of Actinium-225 (Ac-225), a radionuclide for developing the next generation of therapeutic radiopharmaceuticals. The agreement aims to increase access to Ac-225, which is vital for advancing the development and clinical research efforts of Full-Life Technologies.

Clinical Research Eckert & Ziegler Full-Life Technologies Actinium-225 Supply Agreement Therapeutic Radiopharmaceuticals
PRESS RELEASE

published on 10/23/2023 at 09:00, 2 years 11 months ago

Eckert & Ziegler to Supply Ablaze Pharmaceuticals with Lutetium-177 for Clinical Trials

Accesswire

Published on 10/02/2026 at 00:35, 2 hours 52 minutes ago

Medicure Announces Grant of Stock Options
Published on 10/02/2026 at 00:30, 2 hours 57 minutes ago

Immutable Holdings Provides Corporate Update
Published on 10/01/2026 at 23:05, 4 hours 22 minutes ago

Vox Royalty Expands Revolving Credit Facility Up to $150 Million and Strengthens Leadership Team
Published on 10/01/2026 at 22:00, 5 hours 27 minutes ago

Golden Minerals Company Announces New Management Appointments and Resignation of Mr. Pablo Castanos
Published on 10/01/2026 at 19:05, 8 hours 22 minutes ago

PEL 90 Participating Interest Exchange with Chevron

View all ACCESSWIRE

EQS Group

Published on 10/02/2026 at 00:01, 3 hours 26 minutes ago

PolyPeptide publishes the invitation to its extraordinary general meeting of shareholders on 26 October 2026
Published on 10/01/2026 at 23:15, 4 hours 11 minutes ago

CaseBioscience® Joins Team Awarded Up to $7.3 Million by ARPA-H to Advance Ambient Preservation of Cell Therapies
Published on 10/01/2026 at 20:45, 6 hours 41 minutes ago

Ditto Named a Product Leader in KuppingerCole Analysts Leadership Compass for Identity Verification
Published on 10/01/2026 at 20:30, 6 hours 57 minutes ago

Eleving Group prices EUR 200 million senior secured bonds at 9% in private placement – EUR 25 million exchange offer to follow
Published on 10/01/2026 at 18:55, 8 hours 31 minutes ago

Ondo Finance Announces Expansion of Ondo Intelligent Portfolios to Seven With New Magnificent 7, AI and Targeted Portfolios

Les Echos

Published on 10/01/2026 at 19:00, 8 hours 27 minutes ago

AMA CORP PLC reduces its cost base while preserving XpertEye’s key functions
Published on 10/01/2026 at 18:40, 8 hours 46 minutes ago

Monthly disclosure of the total number of shares and voting rights - September 2026
Published on 10/01/2026 at 18:05, 9 hours 22 minutes ago

Covivio - Information on total number of voting rights and share capital
Published on 10/01/2026 at 18:00, 9 hours 26 minutes ago

Saint-Gobain completes the acquisition of Xypex (North America), a leader in high value-added waterproofing solutions
Published on 10/01/2026 at 17:55, 9 hours 31 minutes ago

Disclosure of transactions in own shares from September 28 to September 30, 2026

View all LES ECHOS COMFI WIRE